- Citations, last 5 years
- 55
- Works, last 5 years
- 11
- h-index
- 52
- Scientists listed
- 0
- Grants since 2016
- 17
Grants received
2023–2024 · contract · N01
Task V32: MANUFACTURE OF INFLUENZA VIRUS HUMAN CHALLENGE MATERIAL FOR PHASE 1 AND 2
Suneel Singh · IDT Biologika (Germany) · funded by National Institutes of Health
2023–2027 · contract · N01
Task V32: Manufacture of Influenza Virus Human Challenge Material for Phase I/II Clinical Testing
Suneel Singh · IDT Biologika (Germany) · funded by National Institutes of Health
2020–2024 · contract · N01
Task V09: Development and Manufacture of Toxoid Fusion 3XSTAN12S-MNLTR192G/L211A and CFA/I/II/IV Master Banks
Heidi Trusheim · IDT Biologika (Germany) · funded by National Institutes of Health
2020–2021 · grant · Infektion
MSarsCoV2 - Entwicklung eines rekombinanten viralen Vektorimpfstoffes zur aktiven Immunisierung von Risikogruppen gegen klinische SARS-2 Coronavirus Infektionen
IDT Biologika (Germany) · funded by Bundesministerium für Bildung und Forschung
2019 · contract · N01
Task V05: Manufacture of E. Coli Master Cell Banks for Staphylococcus aureus
Andreas Neubert · IDT Biologika (Germany) · funded by National Institutes of Health
2018–2028 · contract · N01
Task V25: PROCESS DEVELOPMENT FOR VACCINE CANDIDATES INCLUDING SARS-COV-2
Andreas Neubert · IDT Biologika (Germany) · funded by National Institutes of Health
2018–2028 · contract · N01
Task V08: Process Development for Scale-up of Vero Cells on Micro-Carriers for Manufacturing of a Live-Attenuated RSV Vaccine
Arbelo Cristina · IDT Biologika (Germany) · funded by National Institutes of Health
2018–2028 · contract · N01
Task V34: Master Cell Banks Manufacturing for Next Generation SARS-CoV-2 Vaccines
Heidi Trusheim · IDT Biologika (Germany) · funded by National Institutes of Health
2018–2028 · contract · N01
Task V09: Development and Manufacture of Toxoid Fusion Master Banks
Andreas Neubert · IDT Biologika (Germany) · funded by National Institutes of Health
2018–2028 · contract · N01
Task V34: Master Cell Banks Manufacturing for Next Generation SARS-CoV-2 Vaccines
Heidi Trusheim · IDT Biologika (Germany) · funded by National Institutes of Health
2018–2028 · contract · N01
Task V26: MASTER CELL BANKS MANUFACTURING FOR PANDEMIC PREPAREDNESS
Andreas Neubert · IDT Biologika (Germany) · funded by National Institutes of Health
2018–2028 · contract · N01
Task V08: Process Development for Scale-up of Vero Cells on Micro-Carriers for Manufacturing of a Live-Attenuated RSV Vaccine
Arbelo Cristina · IDT Biologika (Germany) · funded by National Institutes of Health
2018–2028 · contract · N01
Task V09: Development and Manufacture of Toxoid Fusion Master Banks
Andreas Neubert · IDT Biologika (Germany) · funded by National Institutes of Health
2018–2028 · contract · N01
Task V28: Process Development and Master Bank Production for a Staph aureus Vaccine Candidate
Andreas Neubert · IDT Biologika (Germany) · funded by National Institutes of Health
2018–2028 · contract · N01
Vaccine Manufacturing and Characterization Services
Andreas Neubert · IDT Biologika (Germany) · funded by National Institutes of Health
2018–2028 · contract · N01
Task V26: MASTER CELL BANKS MANUFACTURING FOR PANDEMIC PREPAREDNESS
Andreas Neubert · IDT Biologika (Germany) · funded by National Institutes of Health
2016–2019 · grant · KMU-innovativ: Biotechnologie-BioChance
KMU-innovativ-16: StabVacHepB - Präklinische Evaluierung eines thermostabilen, therapeutischen Prime/Boost Hepatitis B Impfstoff-Prototyps, Teilprojekt IDT Biologika GmbH
IDT Biologika (Germany) · funded by Bundesministerium für Bildung und Forschung